5.4 Hypoglycemia with Concomitant Use of Insulin Secretagogues or Insulin Patients receiving RYBELSUS or OZEMPIC tablets in combination with an insulin secretagogue (e.g., sulfonylurea) or insulin may have an increased risk of hypoglycemia, including severe hypoglycemia [see Adverse Reactions (6.1), Drug Interactions (7)]
That number rises to 35% among Millennials, compared to 20% of Gen X and Boomers
Everyone's different: What works for one person might not work for another
Our dedicated medical team provides a personalized approach to care, carefully assessing each patients goals, medical history, and lifestyle to determine the most suitable and effective medication and treatment plan
Semaglutides higher rate of weight loss makes it a strong choice, while topiramate can also be a valuable part of a weight-loss plan
Click on the arrows at the top of each section to read more